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During November 2008–July 2009, we investigated the 
origin of unknown fever in Senegalese patients with a nega-
tive malaria test result, focusing on potential rickettsial in-
fection. Using molecular tools, we found evidence for Rick-
ettsia felis–associated illness in the initial days of infection 
in febrile Senegalese patients without malaria.
F
lea-borne spotted fever is widely distributed through-
out the world (1,2). The causative agent is Rickettsia 
felis, an obligate intracellular bacterium (2,3). Usually R. 
felis infection causes mild to moderate disease character-
ized by fever, cutaneous rash (sometimes with an inocula-
tion eschar), and neurologic and digestive signs (1–3). The 
pathogen has been detected in numerous arthropods, but 
the main reservoirs are Ctenocephalides spp. ﬂ  eas, which 
are ectoparasites of domestic cats and dogs (2). Mammals 
that carry ﬂ  eas around humans contribute to accidental in-
fection of humans with R. felis after ﬂ  ea bites (2,4).
R. felis infection is generally diagnosed on the basis of 
both serologic assays and bacterial DNA detection by PCR 
(2–4). In Africa, human R. felis infections have been re-
ported in Tunisia (5) but not in Senegal. One case of murine 
typhus, induced by R. typhi, was reported in Spain in an im-
migrant from Senegal (6). Recently, the high incidence of 
rickettsial diseases was noted in international travelers from 
sub-Saharan Africa (7). However, because rickettsiosis often 
is misdiagnosed, in the incidence of arthropod-borne spotted 
fever in humans in Africa may be underestimated (4).
The objective of our study was to investigate the origin 
of unknown fever in Senegalese patients who had a negative 
test result for malaria. We focused on potential Rickettsia 
spp. infection as a cause of fever.
The Study
We conducted interviews and sampling during No-
vember 2008–July 2009 in 2 rural Senegalese villages in 
the Sine-Saloum region: Dielmo (13°43′N, 16°24′W) and 
Ndiop (13°41′N, 16°23′W) (8). The villages were included 
in a longitudinal prospective study, initiated in 1990, for 
investigations of host–parasite relationships (8,9). At the 
beginning of the study, all participants, including parents or 
legal guardians of all children, gave written individual in-
formed consent. The national ethics committee of Senegal 
and the local ethics committee of Mediterranean Univer-
sity, Marseille, France, approved this project.
Medical examination and blood sampling were con-
ducted for each person who had a fever >37.5°C. Approxi-
mately 200 μL (3–4 drops) of whole blood was collected 
from each patient by lancet stick of a ﬁ  ngertip for malaria 
tests and DNA extraction. Our study used only samples 
negative for Plasmodium spp. The ﬁ  rst step of DNA extrac-
tion was conducted in the village dispensary by using the 
QIAamp kit (QIAGEN, Hilden, Germany). Binding and 
washing of samples with QIAGEN columns was performed 
with an adapted manual pump (Fisher Scientiﬁ  c Inc, Stras-
bourg, France). Columns were stored at 4°C until ﬁ  nal elu-
tion was performed in Marseille, France.
We screened 204 samples from 134 patients by 
quantitative real-time PCR (qPCR) for all spotted fever 
group rickettsiae with Rickettsia-speciﬁ  c gltA gene–based 
RKND03 system. Positive results were conﬁ   rmed by a 
newly designed real-time PCR primer and probe combi-
nation based on the RC0338 gene (Table 1). Appropriate 
handling and DNA extraction are controlled by qPCR of 
the β-actin gene (Table 1). We analyzed data using Epi Info 
software, version 3.4.1 (Centers for Disease Control and 
Prevention, Atlanta, GA, USA).
A total of 103 patients were from Dielmo (391 inhabit-
ants), and 31 were from Ndiop (313 inhabitants). Seventy-
two patients were female, and 90 (67%) were >10 years 
of age. No one died during the study, and all patients with 
identiﬁ  ed rickettsiae infection completely recovered.
We identiﬁ  ed 9 samples from 8 patients (6%) posi-
tive by both genus-speciﬁ  c qPCR systems (Table 1). The 
following sequencing of nested PCR gltA gene amplicons 
from all positive samples showed 100% homology with R. 
felis URRWXCal2 (GenBank accession no. CP000053) 
(10). Furthermore, all positive samples were conﬁ  rmed by 
R. felis species–speciﬁ  c qPCR. One girl 6 years age had 
2  R. felis–positive blood samples 1.5 months apart. No 
samples were positive for typhus group rickettsiae, and 1 
was was positive for R. conorii by sequencing of amplicons 
(data not shown).
The prevalence of ﬂ  ea-borne spotted fever in all tested 
samples was 4.4% (9/204). Monthly incidence for positive 
samples was 4.76% (1/21) in December, 4.76 % (2/42) in 
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January, 16.66% (3/18) in April, 6.89% (2/29) in June, and 
2.38% (1/42) in July. Seven patients lived in Dielmo, and 1 
lived in in Ndiop. The overall incidence was 1.7% in Diel-
mo and 0.3% in Ndiop (7/391 vs. 1/313; p = 0.06), and for 
children <10 years of age 3.5% (5/143) in Dielmo and 0.9% 
(1/109) in Ndiop. The incidence of ﬂ  ea-borne spotted fever 
was highest among children <10 years of age (6/252 vs. 
2/452; p = 0.02). The average age of infected patients was 
15 years (range 2–57 years). Clinical manifestations are 
detailed in Table 2. No rashes and no eschars were found 
during examination.
Conclusions
Our study provides molecular evidence for R. felis 
infection in West Africa in the initial days of infection 
in febrile Senegalese patients who did not have malaria. 
This infection can be easily misdiagnosed because it lacks 
speciﬁ  c signs (2,3). We developed a 2-step DNA extrac-
tion protocol from collected whole blood. The ﬁ  rst step, 
directly performed in the rural villages far from standard 
laboratory facilities, improved sample storage and limited 
contamination. Accordingly, this eliminated the need to ei-
ther mount a complete DNA extraction laboratory in the 
ﬁ  eld or to transport fragile samples, such as human blood, 
from a remote site. This method can be used for research of 
other infectious diseases in rural area and in other develop-
ing countries.
The major clinical signs and symptoms in our study 
were fever associated with weakness, headache with sleep 
disorders, and digestive and respiratory signs; we also 
noted a lack of cutaneous rash or inoculation eschar (2–5). 
Another rickettsial study in an indigenous African popula-
tion reported that cutaneous rash might be imperceptible in 
patients with pigmented skin (11).
Interestingly, a 6-year-old child had 2 positive blood 
samples for R. felis infection; the samples were taken at 
1.5 month intervals, which raises the question of potential 
reinfection, chronic bacteremia, or relapse. Unfortunately, 
the girl was not treated with antimicrobial drugs between 
these episodes because the samples arrived together at the 
laboratory for molecular diagnosis. Relapses have been 
described for other rickettsial diseases such as epidemic 
typhus with late relapse (Brill-Zinsser disease) (12) and 
scrub typhus with early relapse (13). Our study identiﬁ  ed 
a higher attack rate of ﬂ  ea-borne spotted fever in children 
<10 years of age with an attack rate of 3.5% in Dielmo 
during a 9-month period. Some reports of rickettsial dis-
eases in sub-Saharan Africa indicate more infection in 
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Table 1. Target sequences, primers and probes used in a study of Rickettsia felis, rural Senegal, November 2008–July 2009 
Quantitative real-time PCR 
designation and specificity  Target gene  Forward primer (5ƍ o 3ƍ) Reverse  primer  (5ƍ o 3ƍ) Probe 
RKND03 system; 
Rickettsia genus-specific 
gltA GTG-AAT-GAA-AGA-
TTA-CAC-TAT-TTA-T 
GTA-TCT-TAG-CAA-
TCA-TTC-TAA-TAG-C 
6-FAM-CTA-TTA-TGC-
TTG-CGG-CTG-TCG-
GTT-C-TAMRA 
1029 system; Rickettsia 
genus-specific 
Hypothetical protein 
(RC0338 gene) 
GAM-AAA-TGA-ATT-
ATA-TAC-GCC-GCA-AA 
ATT-ATT-KCC-AAA-TAT-
TCG-TCC-TGT-AC 
6-FAM-CTC-AAG-ATA-
AGT-ATG-AGT-TAA-ATG-
TAA-A-TAMRA 
Rpr 331 system; specific 
for typhus group rickettsiae 
Glycosyltransferase TGC-TTC-ATG-GGC-
AAT-GTC-TG 
TTG-AGC-ATA-AAA-
CTG-CCC-TGC-T 
6-FAM-CGC-TGG-ATT-
ATC-AAA-AGA-ATT-AGC-
ACG-TAMRA 
Specific for R. felis Biotin  synthase  ATG-TTC-GGG-CTT-
CCG-GTA-TG 
CCG-ATT-CAG-CAG-
GTT-CTT-CAA 
6-FAM- GCT-GCG-GCG-
GTA-TTT-TAG-GAA-TGG-
G-TAMRA 
ȕ-actin; specific for human 
ȕ-actin gene 
Human ȕ-actin  CAT-GCC-ATC-CTG-
CGT-CTG-GA 
CCG-TGG-CCA-TCT-
CTT-GCT-CG 
6-FAM-CGG-GAA-ATC-
GTG-CGT-GAC-ATT-
AAG-TAMRA 
Table 2. Clinical signs and symptoms in and epidemiologic data for patients with flea-borne spotted fever, rural Senegal, November
2008–July 2009* 
Village  Sampling date  Age, y/sex  Temperature, °C  Signs and symptoms 
Dielmo 2009 Jun  57/F  38.4 Fatigue 
2009 Apr  40/F 39.5 Chills, fatigue, headache, poor appetite, thirst, pharyngitis, 
sleep disorders, rhinitis, urinary pain 
2009 Jun 2/F  38 Fatigue 
2009 Jan  2/M 38.1 Cough, rhinitis, 
2009 Apr  3/M 38.1 Poor appetite, cough, sleep disorders 
2009 Jul  3/M 38.5 Headache, fatigue, poor appetite, sleep disorders 
2008 Dec 6/F  39.7 Headache 
2009 Jan  38.5 Headache 
Ndiop 2009 Apr  10/F  38.7 Fatigue, headache, nausea, vomiting 
*Fever was part of the case definition and therefore part of the clinical picture for all patients. younger persons in whom the disease might be mild or 
subclinical (14).
The incidence of ﬂ  ea-borne spotted fever was high-
er in Dielmo than in Ndiop. Notably, tick-borne relaps-
ing fever, malaria, and Q fever also are more prevalent 
in Dielmo than in Ndiop (8,9). Reasons for the signiﬁ  -
cantly different prevalence of these infectious diseases in 
the 2 geographically close villages remain unexplained. 
Our preliminary work over 9 months did not determine 
a seasonal variation, but we noted more cases in April. 
Rickettsiae, including R. felis, have not been reported as 
background organisms that may circulate undetected in 
the blood of humans and thus be detected by chance. Nev-
ertheless, future work on the clariﬁ  cation of the role of 
Rickettsia spp. in public health will include the study of 
healthy controls from appropriate cohorts.
Finally, we believe that the incidence of R. felis in-
fection is largely underestimated and may be responsible 
in Africa for many cases of uneruptive fevers of unknown 
origin, including those associated with respiratory, diges-
tive, and neurologic signs. We can speculate that ﬂ  ea-borne 
spotted fever might be an important neglected public health 
concern not only in North Africa but also in sub-Saharan 
Africa. Children are particularly vulnerable to this emerg-
ing infection.
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